Who owns EXOZYMES INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EXOZ from SEC Form 13F filings across 10 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 10 institutions disclosed 124,554 shares of EXOZYMES INC. worth $1.0M — about 1.4% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
10
13F holders
$1.0M
value, 2026 filers
1.4%
of shares outstanding (124,554 sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of EXOZ's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 54,985 | $463,524 | 0.0% | 0.6% | +147.8% |
| 2 | Davidson Kahn Capital Management, LLCNEW | 25,000 | $210,750 | 0.1% | 0.3% | new |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 23,406 | $197,312 | 0.0% | 0.3% | +6.9% |
| 4 | BlackRock, Inc. | 9,610 | $81,012 | 0.0% | 0.1% | +41.4% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 9,426 | $79,461 | 0.0% | 0.1% | 0.0% |
| 6 | MORGAN STANLEY | 1,250 | $10,538 | 0.0% | 0% | 0.0% |
| 7 | Tower Research Capital LLC (TRC) | 349 | $2,942 | 0.0% | 0% | -73.5% |
| 8 | MERCER GLOBAL ADVISORS INC /ADVNEW | 250 | $2,108 | 0.0% | 0% | new |
| 9 | UBS Group AG | 203 | $1,711 | 0.0% | 0% | +745.8% |
| 10 | BARCLAYS PLCNEW | 75 | $632 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.